Grade: Pharmaceutical Grade

Factory Location: Lianyungang, Jiangsu, China

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Temozolomide is an oral chemotherapy drug. It is analkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.
Temozolomide API and Temozolomide for Injection has got Chinese local GMP certificate.